6681 — BrainAurora Medical Technology Income Statement
0.000.00%
Last trade - 00:00- HK$8.31bn
- HK$8.36bn
- CNY122.31m
Annual income statement for BrainAurora Medical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 2.3 | 11.3 | 67.2 | 122 |
| Cost of Revenue | ||||
| Gross Profit | 1.3 | 3.3 | 32.1 | 54 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 694 | 495 | 406 | 299 |
| Operating Profit | -691 | -483 | -339 | -177 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -698 | -502 | -359 | -199 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -698 | -502 | -359 | -199 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -698 | -502 | -359 | -198 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -698 | -502 | -359 | -198 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.551 | -0.397 | -0.263 | -0.145 |